Related Experiment Video
Updated: Jun 2, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Predictive models for diabetes patients in Medicaid.
Christopher S Hollenbeak1, Mark Chirumbole, Benjamin Novinger
1Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
This study developed a gender-specific predictive model using claims data to identify individuals at higher risk for hospitalization, high expenses, or death. The model shows accuracy comparable to existing tools for care management targeting.
Area of Science:
- Health informatics
- Predictive analytics
- Population health management
Background:
- Predictive modeling aids in identifying individuals at risk for adverse health outcomes.
- Fee-for-service Medicaid programs can benefit from tools to manage high-risk populations.
Purpose of the Study:
- To develop and validate a gender-specific predictive model using demographic, medical, and pharmacy claims data.
- To identify individuals with elevated future risk of hospitalization, claims expense, or death within a Medicaid population.
Main Methods:
- Utilized demographic, medical, and pharmacy claims data from two states.
- Developed a gender-specific predictive model for fee-for-service Medicaid beneficiaries.
- Assessed model performance using the area under the receiver operating characteristic curve (AUC).
Main Results:
- The predictive model demonstrated varying accuracy (AUC 0.608–0.834) depending on age and outcome of interest.
- Model performance was comparable to existing predictive tools for risk stratification.
- The model effectively identified individuals at elevated risk within the studied diabetes populations.
Conclusions:
- The developed predictive model accurately identifies individuals at high risk for adverse health outcomes in a Medicaid population.
- This tool can assist in targeting patient enrollment for population-based care management programs.
- Gender-specific modeling enhances the precision of risk prediction for diverse patient groups.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions